A Review of Clinical Studies of Chinese Medicine Treatment of Polycystic Kidney Disease Using the CNKI Database

• Published in: The Journal of Internal Korean Medicine Vol. 42; no. 3; pp. 225 - 238
• Main Authors: Ju, Ah-ra, Park, Mi-so, Choi, Yo-sup, Choo, Won-jung, Baek, Hye-kyung, Park, Mu-jin
• Format: Journal Article
• Language: English
• Published: 30.06.2021
• ISSN: 1226-9174
• DOI: 10.22246/jikm.2021.42.3.225

Objective: This research reviews and investigates the trends in recent clinical studies of polycystic kidney disease (PKD) in China. Method: We searched for clinical studies discussing Oriental medicine-based treatments for PKD in the China National Knowledge Infrastructure (CNKI) database. Thirteen clinical articles published from 2001 to 2019 were analyzed. The search focused on the authors, publication year, type of study, purposes of study, method and duration of treatment, evaluation criteria, and results of the selected articles. Results: Of the articles from the database, 9 case series and 4 randomized controlled trials (RCTs) were analyzed. Ten articles used herbal medicine; 4 used herbal medicine for external use. Gamigyejibokryeong-hwan was the most common herbal prescription. The most frequently used herb was Polia Sclerotium (茯苓), and Cnidii Rhizoma (川芎) was employed in all the external uses. All 13 studies confirmed the efficacy of Oriental medicine treatments. Conclusion:1. Scientifically designed and more varied clinical studies are required to develop treatments for PKD.2. The current study could be used as basic data in future clinical studies on treatment and further studies of PKD.